Suboptimal Bone Health Management After Kidney Transplantation and Dialysis Initiation

Background: Patients undergoing kidney transplantation (KT) or initiating dialysis are at high risk for osteoporosis and fractures. However, real-world patterns of bone mineral density (BMD) testing and treatment initiation remain unclear. Methods: We analyzed nationwide insurance claims data for 34,758 KT recipients and 63,674 incident dialysis patients treated between 2003 and 2020. Rates and timing of BMD testing, osteoporosis treatment initiation, and fracture incidence were compared. Osteoporotic fractures were identified using ICD-10 codes, and time-to-event analyses were conducted. Results: KT recipients were younger, predominantly male, and had more prior BMD testing but fewer prior fractures than incident dialysis patients. During follow-up, 63.9% of KT recipients underwent BMD testing, but only 48.6% underwent testing within 1 year post-transplant (median 374 days [IQR 37–1064]). In contrast, only 29.2% of dialysis patients received BMD testing (p < 0.001), with significantly delayed timing. Osteoporosis treatment was prescribed for 15.6% of KT recipients (19.8% within 1 year) and 7.6% of dialysis patients (30.3% within 1 year). Although prescription rates were lower in dialysis, treatments tended to be prescribed earlier. Osteoporotic fractures occurred in 10.6% of KT recipients (median 1990 days [834–3512]), with 11.9% occurring within 1 year. Among dialysis patients, 13.1% experienced fractures (median 1155 days [324–2403]), with 25.0% occurring within 1 year. The 1-year fracture risk was comparable between groups in those with prior fracture. However, among those without prior fracture, dialysis patients had a significantly higher risk (HR 1.49, 95% CI 1.28–1.73). Conclusion: Despite high fracture risk, both BMD testing and osteoporosis treatment remain underutilized in KT and dialysis patients. The low treatment rate may be partly attributable to the limited use of BMD testing, which is often required for reimbursement. Early and proactive bone health assessment is particularly critical in dialysis patients, where fractures occur more frequently and earlier.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.20259br54tk8
Primary Topic
Bone and Joint Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Suboptimal Bone Health Management After Kidney Transplantation and Dialysis Initiation

Youngjoo Kwon, Ji Eun Kim
Journal of the American Society of Nephrology
Bone and Joint Diseases
article

Suboptimal Bone Health Management After Kidney Transplantation and Dialysis Initiation

Youngjoo Kwon, Ji Eun Kim
article en

Abstract

Background: Patients undergoing kidney transplantation (KT) or initiating dialysis are at high risk for osteoporosis and fractures. However, real-world patterns of bone mineral density (BMD) testing and treatment initiation remain unclear. Methods: We analyzed nationwide insurance claims data for 34,758 KT recipients and 63,674 incident dialysis patients treated between 2003 and 2020. Rates and timing of BMD testing, osteoporosis treatment initiation, and fracture incidence were compared. Osteoporotic fractures were identified using ICD-10 codes, and time-to-event analyses were conducted. Results: KT recipients were younger, predominantly male, and had more prior BMD testing but fewer prior fractures than incident dialysis patients. During follow-up, 63.9% of KT recipients underwent BMD testing, but only 48.6% underwent testing within 1 year post-transplant (median 374 days [IQR 37–1064]). In contrast, only 29.2% of dialysis patients received BMD testing (p < 0.001), with significantly delayed timing. Osteoporosis treatment was prescribed for 15.6% of KT recipients (19.8% within 1 year) and 7.6% of dialysis patients (30.3% within 1 year). Although prescription rates were lower in dialysis, treatments tended to be prescribed earlier. Osteoporotic fractures occurred in 10.6% of KT recipients (median 1990 days [834–3512]), with 11.9% occurring within 1 year. Among dialysis patients, 13.1% experienced fractures (median 1155 days [324–2403]), with 25.0% occurring within 1 year. The 1-year fracture risk was comparable between groups in those with prior fracture. However, among those without prior fracture, dialysis patients had a significantly higher risk (HR 1.49, 95% CI 1.28–1.73). Conclusion: Despite high fracture risk, both BMD testing and osteoporosis treatment remain underutilized in KT and dialysis patients. The low treatment rate may be partly attributable to the limited use of BMD testing, which is often required for reimbursement. Early and proactive bone health assessment is particularly critical in dialysis patients, where fractures occur more frequently and earlier.

Journal of the American Society of NephrologyVol. 36(10S)
Korea University Medical Center (KR)
Openalex Percentile: Top 61%
Bone and Joint Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Suboptimal Bone Health Management After Kidney Transplantation and Dialysis Initiation — Youngjoo Kwon, Ji Eun Kim · Journal of the American Society of Nephrology (2025) | TGRS Research Map | TGRS